Clinical Trials Browser

Phase 2/3 × masitinib × Gastrointestinal × Clear all

NCT03556956 2020-12-08

Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer

Phase 2/3 Completed

Gastrointestinal

Colorectal Cancer Metastatic